Literature DB >> 17244278

Persistent detrusor overactivity after transurethral resection of the prostate is associated with reduced perfusion of the urinary bladder.

Michael Mitterberger1, Leo Pallwein, Johann Gradl, Ferdinand Frauscher, Hannes Neuwirt, Nicolai Leunhartsberger, Hannes Strasser, Georg Bartsch, Germar-Michael Pinggera.   

Abstract

OBJECTIVES: To elucidate, in patients with benign prostatic hyperplasia (BPH), how often detrusor overactivity (DOA) is persistent after transurethral resection of the prostate (TURP) and if perfusion of the lower urinary tract influences postoperative outcomes. PATIENTS AND METHODS: Fifty men with urodynamically confirmed DOA and bladder outlet obstruction due to BPH had a TURP. Before and 1 year after TURP the International Prostate Symptom Score (IPSS), quality of life (QoL) score, prostate-specific antigen (PSA) level and total prostatic volume (TPV) were evaluated. Also, the lower urinary tract was evaluated using pressure-flow studies and transrectal colour Doppler ultrasonography to assess the vascular resistive index (RI) as a variable of the perfusion of the lower urinary tract.
RESULTS: After TURP the IPSS, QoL score, PSA level and TPV decreased. Cystometric measurements showed that in 15 (30%) patients DOA was persistent after TURP. The mean (sd) maximum urinary flow rate increased from 9.20 (4.03) to 15.98 (4.62) mL/s and postvoiding residual urine volumes decreased from 109.38 (73.71) to 29.24 (45.00) mL. When men with persistent DOA (15 patients; group 1) were compared with those with no DOA after TURP (35; group 2) there was a statistically significantly higher RI of the bladder vessels in group 1, at 0.86 (0.068) than in group 2, at 0.68 ( 0.055) (P < 0.001).
CONCLUSIONS: Persistent DOA in men after TURP seems to be associated with increased vascular resistance of the bladder vessels with subsequent reduced perfusion and hypoxia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17244278     DOI: 10.1111/j.1464-410X.2006.06735.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  16 in total

1.  Refractory overactive bladder after urethrolysis for bladder outlet obstruction: management with sacral neuromodulation.

Authors:  Jonathan S Starkman; John W Duffy; Christopher E Wolter; Melissa R Kaufman; Harriette M Scarpero; Roger R Dmochowski
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-08-02

Review 2.  Advanced therapeutic directions to treat the underactive bladder.

Authors:  Phillip P Smith; Pradeep Tyagi; George A Kuchel; Subrata Pore; Christopher Chermansky; Michael Chancellor; Naoki Yoshimura; Peter Levanovich
Journal:  Int Urol Nephrol       Date:  2014-09-20       Impact factor: 2.370

3.  Are blood vessels a target to treat lower urinary tract dysfunction?

Authors:  Martin C Michel; Russ Chess-Williams; Sharath S Hegde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-05-31       Impact factor: 3.000

4.  The effect of pentoxifylline on detrusor muscle contractility after partial urethral obstruction in a rat model.

Authors:  Mehdi Shirazi; Hossein Mirkhani; Ahmad Monabbati; Soheil Moghtadernejad; Alireza Aminsharifi
Journal:  Int Urol Nephrol       Date:  2015-07-19       Impact factor: 2.370

5.  Mammalian target of rapamycin (mTOR) induces proliferation and de-differentiation responses to three coordinate pathophysiologic stimuli (mechanical strain, hypoxia, and extracellular matrix remodeling) in rat bladder smooth muscle.

Authors:  Karen J Aitken; Cornelia Tolg; Trupti Panchal; Bruno Leslie; Jeffery Yu; Mohamed Elkelini; Nesrin Sabha; Derrick J Tse; Armando J Lorenzo; Magdy Hassouna; Darius J Bägli
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

6.  Comparative Analysis of Outcomes after Transurethral Resection of the Prostate according to Prostate Shape Shown by Transrectal Ultrasonography.

Authors:  Hyo Serk Lee; Sung Jin Kim; Jae Mann Song; Kwang Jin Kim; Hyun Chul Chung
Journal:  Korean J Urol       Date:  2010-07-20

Review 7.  Testosterone Replacement Therapy and BPH/LUTS. What is the Evidence?

Authors:  Wesley Baas; Tobias S Köhler
Journal:  Curr Urol Rep       Date:  2016-06       Impact factor: 3.092

8.  Impact of lower urinary tract symptoms/benign prostatic hyperplasia treatment with tamsulosin and solifenacin combination therapy on erectile function.

Authors:  Deok Ha Seo; Sung Chul Kam; Jae Seog Hyun
Journal:  Korean J Urol       Date:  2011-01-24

9.  Late-onset hypogonadism syndrome and lower urinary tract symptoms.

Authors:  Kazuyoshi Shigehara; Mikio Namiki
Journal:  Korean J Urol       Date:  2011-10-19

10.  The Impact of Increased Bladder Blood Flow on Storage Symptoms after Holmium Laser Enucleation of the Prostate.

Authors:  Keisuke Saito; Shin-ichi Hisasue; Hisamitsu Ide; Hiroaki Aoki; Satoru Muto; Raizo Yamaguchi; Akira Tsujimura; Shigeo Horie
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.